ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 151 filers reported holding ARCUS BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43 | -96.5% | 2,400 | -96.5% | 0.00% | -100.0% |
| Q1 2023 | $1,236 | +129.3% | 67,800 | +159.8% | 0.00% | 0.0% |
| Q4 2022 | $539 | -99.9% | 26,100 | -19.9% | 0.00% | -50.0% |
| Q3 2022 | $852,000 | -2.0% | 32,600 | -5.0% | 0.00% | 0.0% |
| Q2 2022 | $869,000 | +52.2% | 34,300 | +109.1% | 0.00% | +100.0% |
| Q3 2021 | $571,000 | +26.9% | 16,400 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $450,000 | +34.7% | 16,400 | +37.8% | 0.00% | +100.0% |
| Q1 2021 | $334,000 | -31.6% | 11,900 | -36.7% | 0.00% | -50.0% |
| Q4 2020 | $488,000 | +122.8% | 18,800 | +46.9% | 0.00% | +100.0% |
| Q3 2020 | $219,000 | -33.4% | 12,800 | -3.8% | 0.00% | 0.0% |
| Q2 2020 | $329,000 | – | 13,300 | – | 0.00% | – |
| Q3 2018 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q2 2018 | $18,000 | – | 1,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |